Key Highlights

  • Solesence (NASDAQ:SLSN) traded at USD 1.16 intraday on November 13, 2026, up 28.89%, on about 2.23 million shares against an average of fewer than 50,000, giving a Market Value of about USD 84.4 million.
  • Third quarter Revenue reached a record USD 20.2 million, up 38% from USD 14.6 million a year earlier, and Net Income was USD 3.7 million against a net loss of USD 1.0 million.
  • Gross Margin widened to 39.3% from 23.8%, and Operating Income was USD 4.0 million compared with an operating loss of USD 0.7 million.
  • Cash was only USD 1.3 million at September 30, 2026, so the company still relies on related-party Credit lines for working capital.

A Record Quarter Drives the Move

The catalyst is clear. On November 12, 2026 Solesence reported record third quarter results, and the shares have rallied in the sessions since. Net revenue rose 38% to about USD 20.2 million from about USD 14.6 million a year earlier. Gross Profit more than doubled to about USD 7.9 million, lifting gross margin to 39.3% from 23.8%. That margin gain carried through to the bottom line: operating income was about USD 4.0 million against a loss of about USD 0.7 million, and net income was about USD 3.7 million, or USD 0.05 per diluted share, against a loss of about USD 1.0 million. Adjusted EBITDA came to about USD 4.3 million compared with a small negative figure a year earlier. Trading Volume shows how unusual the reaction was. About 2.23 million shares changed hands in the November 13 session, compared with an average of fewer than 50,000, and the shares also jumped strongly on November 12. A thinly traded stock re-rating on a profitable quarter can move quickly, which is what has happened here.

What the Business Does

Solesence, based in Romeoville, Illinois, develops and manufactures skin health and sun protection products for beauty and personal care brands, with a focus on mineral based ingredients. It earns most of its revenue as a formulator and producer for other companies rather than selling its own consumer brands at scale. That model makes quarterly revenue lumpy, because it depends on customer orders and product launches. The nine month figures show this clearly: revenue for the first nine months of 2026 was about USD 48.5 million, slightly below USD 49.6 million a year earlier, even after the record third quarter, and nine month net income was about USD 2.5 million, roughly unchanged. Investors are therefore paying for the improvement in margin and the timing of orders in the third quarter, and they will want evidence that the higher margin is structural rather than the result of a favourable product mix in a single period. Solesence (NASDAQ:SLSN) has about 70.6 million shares outstanding.

Balance Sheet and Reporting Points to Watch

The main caution is liquidity. Cash was only about USD 1.3 million at September 30, 2026, little changed from the start of the year, and the company uses credit lines from a related party to fund receivables and inventory. Borrowing under the receivables line fell to about USD 1.0 million from about USD 4.8 million, and the long-term inventory line fell to USD 6.3 million from USD 9.5 million, which suggests the quarter's profit was used to reduce borrowings. Shareholders' Equity was about USD 16.8 million. The company also filed amended quarterly and annual reports on November 10, shortly before the results, and investors should check what was restated. A fourth quarter that holds the higher margin would support the new valuation.

Where Things Stand

Solesence rose 28.89% to USD 1.16 on November 13, 2026 after record third quarter revenue and a swing to profit. The margin gain is the key driver, but cash is thin and nine month revenue is flat. Watch fourth quarter orders, margin and related-party borrowing levels.